Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 28.05.2012Börsentäglich über 11.000 News von 416 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

GRIFOLS SA

18,545 Euro		+0,220
+1,20 %
WKN: A0B6Z3  ISIN: ES0171996012  Ticker-Symbol: OZT  Stuttgart | 25.05.12 | 19:58 Uhr
Aktie:
Branche
Pharma
Aktienmarkt
IBEX-35
NASDAQ Biotech
1-Jahres-Chart
GRIFOLS SA Chart 1 Jahr
1-Woche-Intraday-Chart
GRIFOLS SA 1-Woche-Intraday-Chart

Aktuelle News zur GRIFOLS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
30.03. Grifols Annual Report on Form 20-F for 2011 Filed with SEC on March 29, 201254PR Newswire
BARCELONA, Spain, March 30, 2012 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), announced that it has filed its 2011 Annual Report on Form 20-F with the United States...
Mehr lesen zu:
Grifols Annual Report on Form 20-F for 2011 Filed with SEC on March 29, 2012
26.03. LA Laker Pau Gasol Introduces New Technology Donated by Grifols to Pharmacy at Children's Hospital Los Angeles97PR Newswire
LOS ANGELES, March 26, 2012 /PRNewswire/ -- Los Angeles Lakers' power forward Pau Gasol has partnered with Grifols, a Barcelona-based global health care company with U.S. headquarters...
Mehr lesen zu:
LA Laker Pau Gasol Introduces New Technology Donated by Grifols to Pharmacy at Children's Hospital Los Angeles
15.03. Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects42PR Newswire
BARCELONA, Spain, March 15, 2012 /PRNewswire/ -- Grifols (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), the world's third largest plasma product manufacturer and a pioneer in the research...
Mehr lesen zu:
Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects
14.03. Grifols Study Suggests Repeated Plasmapheresis May Reduce "Bad" LDL Cholesterol Levels While Increasing "Good" HDL Cholesterol Levels in Some Individuals30PR Newswire
MADRID, March 14, 2012 /PRNewswire/ -- Grifols, (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), a global healthcare company that specializes in the production of biological medicines derived from human plasma...
Mehr lesen zu:
Grifols Study Suggests Repeated Plasmapheresis May Reduce "Bad" LDL Cholesterol Levels While Increasing "Good" HDL Cholesterol Levels in Some Individuals
06.12. Victor Grifols selected as "Business Leader of the Year 2011" by the Spain - U.S. Chamber of Commerce44PR Newswire
BARCELONA, Spain, Dec. 6, 2011 /PRNewswire/ -- Victor Grifols Roura, president and managing director of Grifols, has been selected as the "Business Leader of the Year 2011" by...
Mehr lesen zu:
Victor Grifols selected as "Business Leader of the Year 2011" by the Spain - U.S. Chamber of Commerce
05.12. FRA:New Instruments available on XETRA - 06.12.2011-001143Xetra Newsboard
The following instruments on XETRA do have their first trading day 06.12.2011 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 06.12.2011 TrdMod InstCode Exch ISIN Name InstGrp...
Mehr lesen zu:
FRA:New Instruments available on XETRA - 06.12.2011-001
05.12. CAPITAL ADJUSTMENT INFORMATION - 06.12.2011 - 190Xetra Newsboard
FOLGENDE WERTPAPIERE WERDEN AM 06.12.2011 EX KAPITALMASSNAHME GEHANDELT. THE FOLLOWING SHARES ARE TRADED EX CAPITAL ADJUSTMENT ON 06.12.2011. INSTR EXCH ISIN INSTRUMENT NAME ORA XETI NL0000440584 ORDINA...
Mehr lesen zu:
CAPITAL ADJUSTMENT INFORMATION - 06.12.2011 - 1
7 Nachrichten in den letzten 6 Monaten